1. The impact of coronavirus disease 2019 on frozen-thawed embryo transfer outcomes
- Author
-
Junrong Diao, Du Aijun, Xinyan Wang, Shuai Zhang, Ying Han, Nan Xiao, Zhe Pang, Junfang Ma, Yunshan Zhang, and Haining Luo
- Subjects
COVID-19 ,Frozen-thawed embryo transfer ,Pregnancy ,SARS-CoV-2 ,Medicine ,Biology (General) ,QH301-705.5 - Abstract
Background Coronavirus disease 2019 (COVID-19) has raised concerns about its potential effects on human fertility, particularly among individuals undergoing assisted reproductive therapy (ART). However, the impact of COVID-19 on female reproductive and assisted reproductive outcomes is unclear. In this study, we aimed to evaluate the effects of COVID-19 on pregnancy outcomes during frozen-thawed embryo transfer (FET) cycles. Methods This retrospective cohort study included 327 enrolled patients who underwent FET cycles at a single reproductive centre. The study group consisted of patients treated between 1 January 2023 and 31 March 2023 who recently recovered from COVID-19. The embryos for transfer were generated prior to COVID-19 infection. The control group consisted of patients treated between 1 January 2021 and 31 March 2021 who were not infected and did not receive a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Demographic and cycle characteristics and outcomes were compared. Results A total of 160 recovered women and 167 controls were included. The primary outcome—the live birth rate—was similar between the two groups (43.8% vs. 43.1%, P > 0.05). The secondary outcomes, such as the implantation rates (41.2% vs. 39.3%), biochemical pregnancy rates (56.3% vs. 56.3%), clinical pregnancy rates (52.5% vs. 52.1%), early abortion rates (8.3% vs. 12.6%) and ongoing pregnancy rates (46.9% vs. 44.3%), were also similar (P
- Published
- 2024
- Full Text
- View/download PDF